Article content material
BROSSARD, Quebec, July 14, 2023 (GLOBE NEWSWIRE) — ZoomMed Inc. (“ZoomMed” or the “Company”) (NEX: ZMD) is happy to announce the complete revocation as of at this time of the stop commerce order which was issued by the Autorité des marchés financiers and the Ontario Securities Fee on October 5, 2018 pursuant to which all buying and selling within the securities of the Company, whether or not direct or oblique, needed to stop till the order is revoked (the “CTO”). The CTO was issued following the Company’s failure to file, throughout the required time in accordance with securities regulation, its annual audited monetary statements, annual administration’s dialogue and evaluation, and certification of annual filings for its monetary 12 months ended Might 31, 2018. This revocation follows the submitting by ZoomMed of all periodic steady disclosure paperwork offered by the laws.
Article content material
Pursuant to Coverage Assertion 11-207 Respecting Failure-To-File Stop Commerce Orders and Revocations in A number of Jurisdictions, ZoomMed will maintain its annual and particular assembly of shareholders on July 25, 2023.
Article content material
For additional data on ZoomMed, please contact Mr. Yves Marmet, President and Chief Government Officer at data@zoommed.com or go to our Net Website; www.zoommed.com or on SEDAR at www.sedar.com.
Statements made on this press launch that aren’t historic information are “forward-looking statements” and the reader is cautioned that such statements usually are not ensures of future efficiency and that precise developments and outcomes might differ materially from these in such “forward-looking statements”.
